| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 444.428 | 733.039 | 1.873.998 | 2.458.241 | 3.056.192 |
| Total Income - EUR | - | - | - | - | - | 444.498 | 735.366 | 1.884.905 | 2.490.627 | 3.115.258 |
| Total Expenses - EUR | - | - | - | - | - | 339.143 | 520.238 | 1.350.303 | 1.751.817 | 2.314.257 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 105.355 | 215.129 | 534.602 | 738.810 | 801.001 |
| Net Profit/Loss - EUR | - | - | - | - | - | 94.936 | 210.093 | 479.502 | 648.543 | 691.680 |
| Employees | - | - | - | - | - | 0 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Neuro Med Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 51.591 | 43.984 | 91.117 |
| Current Assets | - | - | - | - | - | 114.307 | 502.546 | 1.225.021 | 1.588.242 | 2.688.957 |
| Inventories | - | - | - | - | - | 0 | 165.334 | 220.314 | 190.212 | 153.882 |
| Receivables | - | - | - | - | - | 35.343 | 93.284 | 547.732 | 404.052 | 754.361 |
| Cash | - | - | - | - | - | 78.963 | 243.928 | 193.363 | 386.014 | 472.661 |
| Shareholders Funds | - | - | - | - | - | 94.977 | 285.728 | 479.550 | 820.952 | 691.728 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 19.330 | 216.819 | 797.282 | 808.478 | 2.089.144 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Neuro Med Therapy S.r.l.